This patient presented with advanced renal ... mixed cryoglobulinemia, idiopathic membranoproliferative glomerulonephritis (MPGN), and postinfectious glomerulonephritis. There have also been ...

WARNING: SEVERE HYPERSENSITIVITY REACTIONS Hypersensitivity Reactions Including Anaphylaxis Patients treated with Lamzede have experienced hypersensitivity reactions, including anaphylaxis.

Karen Lewis (JO:LEWJ), the Chief People Officer at Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.75 billion market cap biotech company, recently sold 1,241 shares of common stock. The shares ...

Pascal Deschatelets, the Chief Scientific Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), recently executed a stock transaction involving the sale of company shares. According to a filing with ...

Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...

This known mechanism, together with the identification of CD20 + cells in renal biopsies from patients with ... and leads to a membranoproliferative glomerulonephritis usually accompanied by ...

There's no doubt however that patients will benefit from having ... immune complex membranoproliferative glomerulonephritis (IC-MPGN), C3 glomerulopathy (C3G) and cold agglutinin disease (CAD ...

Patients treated with Elfabrio have experienced hypersensitivity ... and hypotension. A case of membranoproliferative glomerulonephritis with immune depositions in the kidney was reported during ...

This development makes the treatments more attractive to patients seeking effective ... and primary Immune Complex-Membranoproliferative Glomerulonephritis (IC-MPGN).

Herein, we show that Tlr9 is overexpressed in podocytes and the mechanisms which cause its injury and development of membranoproliferative glomerulonephritis (MPGN) in model BXSB/MpJ-Yaa (Yaa) mice.

Read More: Long COVID Doesn’t Always Look Like You Think It Does The vast majority of Long COVID patients will not land in psychiatric wards, but Erin is far from the only one who has.

Iptacopan hydrochloride is under clinical development by Novartis and currently in Phase III for Membranoproliferative Glomerulonephritis (Mesangiocapillary Glomerulonephritis). According to ...